Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial

ग्रंथसूची विवरण
मुख्य लेखकों:	Zhao, Y, Griesel, R, Omar, Z, Simmons, B, Hill, A, van Zyl, G, Keene, C, Maartens, G, Meintjes, G
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	Oxford University Press 2023

Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
द्वारा: Keene, CM, और अन्य
प्रकाशित: (2023)

Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
द्वारा: Keene, CM, और अन्य
प्रकाशित: (2021)

Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
द्वारा: Griesel, R, और अन्य
प्रकाशित: (2023)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial
द्वारा: Zhao, Y, और अन्य
प्रकाशित: (2021)

Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
द्वारा: Kairoonisha Mahomed, और अन्य
प्रकाशित: (2020-07-01)

Dolutegravir for second-line treatment: Programmatic implications of new evidence
द्वारा: Ying Zhao, और अन्य
प्रकाशित: (2022-09-01)

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial [version 1; peer review: 2 approved, 1 approved with reservations]
द्वारा: Zimasa Gcwabe, और अन्य
प्रकाशित: (2021-02-01)

Virologic outcomes with tenofovir-lamivudine-dolutegravir in adults failing PI-based second-line ART
द्वारा: Ying Zhao, और अन्य
प्रकाशित: (2024-04-01)

Guidelines for antiretroviral therapy in adults
द्वारा: G Meintjes, और अन्य
प्रकाशित: (2012-08-01)

Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
द्वारा: Bárbara Thaís Poliselo de Sá, और अन्य
प्रकाशित: (2022-01-01)

Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy
द्वारा: Michelle A. Moorhouse, और अन्य
प्रकाशित: (2018-10-01)

Noncomparative scaling of aromaticity through electron itinerancy
द्वारा: Satadal Paul, और अन्य
प्रकाशित: (2015-10-01)

Initiating antiretroviral therapy
द्वारा: Gary Maartens
प्रकाशित: (2005-05-01)

Weight gain on dolutegravir: Association is not the same as causation
द्वारा: Gary Maartens, और अन्य
प्रकाशित: (2023-05-01)

Searching for a long-acting injectable formulation for the antiretroviral dolutegravir
द्वारा: Anderson Aparecido de Marchi, और अन्य
प्रकाशित: (2019-12-01)

Adult antiretroviral therapy guidelines 2014
द्वारा: G. Meintjes
प्रकाशित: (2014-01-01)

Dolutegravir-Associated Hyperglycemia in a Patient on Highly Active Antiretroviral Therapies
द्वारा: Abosede Grace Adeyeye, और अन्य
प्रकाशित: (2024-09-01)

Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial
द्वारा: Hamideh Abbaspour Kasgari, और अन्य
प्रकाशित: (2024-06-01)

Impact of dolutegravir-based antiretroviral therapy on piperaquine exposure following dihydroartemisinin-piperaquine intermittent preventive treatment of malaria in pregnant women living with HIV
द्वारा: Banda, CG, और अन्य
प्रकाशित: (2022)

THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY
द्वारा: K. M. Dzeranova, और अन्य
प्रकाशित: (2015-12-01)

Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
द्वारा: Alessandra Latini, और अन्य
प्रकाशित: (2019-12-01)

Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients
द्वारा: Yogesh Suresh Punekar, और अन्य
प्रकाशित: (2019-12-01)

An Examination Of Perceived Quality, Satisfaction, And Loyalty Relationship : Applicability of Comparative and Noncomparative Evaluation
द्वारा: Perpustakaan UGM, i-lib
प्रकाशित: (2006)

Stereotactic Biopsy for Brainstem Lesions: A Meta-analysis with Noncomparative Binary Data
द्वारा: Lin He, और अन्य
प्रकाशित: (2021-12-01)

Effect of Rifabutin in Dolutegravir Dosing: A Case Series
द्वारा: Maria A. Mendoza MD, और अन्य
प्रकाशित: (2022-07-01)

Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function
द्वारा: Chang Huang, और अन्य
प्रकाशित: (2023-03-01)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
द्वारा: Dario Cattaneo, और अन्य
प्रकाशित: (2020-03-01)

Alirokumab in the practice of a multidisciplinary outpatient hospital: results of an open, noncomparative prospective study
द्वारा: A. O. Bueverov, और अन्य
प्रकाशित: (2020-12-01)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
द्वारा: Enkosi Mondleki, और अन्य
प्रकाशित: (2022-12-01)

Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
द्वारा: Helen van der Plas, और अन्य
प्रकाशित: (2013-01-01)

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
द्वारा: Marion Tisseraud, और अन्य
प्रकाशित: (2022-05-01)

Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir
द्वारा: Erik Belfrage, और अन्य
प्रकाशित: (2023-07-01)

Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study
द्वारा: H R Jerajani, और अन्य
प्रकाशित: (2011-01-01)

Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study
द्वारा: Jeetesh V Patel, और अन्य
प्रकाशित: (2005-12-01)

Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy
द्वारा: Graeme Meintjes, और अन्य
प्रकाशित: (2015-12-01)

Metabolic Syndrome and Associated Factors Among People Living With HIV on Dolutegravir-Based Antiretroviral Therapy in Northern Tanzania
द्वारा: Tumaini E. Mirai MD, MMed, और अन्य
प्रकाशित: (2024-12-01)

Viremia and HIV drug resistance among people receiving dolutegravir versus efavirenz-based first-line antiretroviral therapy
द्वारा: Dorward, J, और अन्य
प्रकाशित: (2024)

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing
द्वारा: Cecilia L. Moore, और अन्य
प्रकाशित: (2021-01-01)

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy
द्वारा: Meintjes Graeme A, और अन्य
प्रकाशित: (2009-12-01)

Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial

समान संसाधन

समान संसाधन